News

Nominations now open for 2025 EURORDIS Black Pearl Awards

Nominations now open for 2025 EURORDIS Black Pearl Awards

Nominations for the 2025 EURORDIS Black Pearl Awards are now open, inviting the rare disease and healthcare communities to honour outstanding efforts to improve the lives of those affected by rare diseases. Each February since 2012, the award ceremony has celebrated exceptional achievements with annual ceremonies. The varied award categories recognise individuals, organisations, companies, researchers, scientists, media, and policymakers. These efforts aim to improve the lives of 30 million people in Europe and 300 million worldwide. Join in celebrating these contributions by submitting your nominations now by Friday 30 July.

Patients, Rare Diseases
Member News

Don’t miss your chance to nominate your star of the rare disease community, or enter yourself, for the 2025 EURORDIS Black Pearl Awards!

These award categories recognise the outstanding efforts of individuals, organisations, companies, researchers, scientists, media, and policy makers in bringing about change to improve the lives of the 30 million people in Europe and 300 million worldwide living with a rare disease.

Among all the nominations received, the EURORDIS Board of Directors will select the award recipients in October 2024.

A few finalists will be selected for the Social Media Award, for which the winners will be determined by a public vote. The awardees will then be presented with their awards at the official Ceremony in February 2025, to mark the occasion of Rare Disease Day.

Learn more about the award categories below and click to make your nomination in just a few minutes.

Discover more about EURORDIS – Rare Diseases Europe:

EURORDIS – Rare Diseases Europe is a unique, non-profit alliance of over 1000 rare disease patient organisations from 74 countries that work together to improve the lives of over 30 million people living with a rare disease in Europe. By connecting patients, families and patient groups, as well as by bringing together all stakeholders and mobilising the rare disease community, EURORDIS strengthens the patient voice and shapes research, policies and patient services.

NEWS​

Related News

4C Accelerator – Apply for the free qualification program for MedTech startups

12 Dec 2024
Until January 17, 2025 founders in the MedTech sector can apply for the free & funded “4C Accelerator”. The programm enables founders in the MedTe...

Future4care International Call4Applications 2025 – Now Open!

10 Dec 2024
Are you a digital health startup looking to expand into France and Germany? Don’t miss the opportunity to join Future4care’s one-year, equity-free acc...

AGE-WELL, Canada’s technology and aging network, releases its 2023-2024 Annual Report

10 Dec 2024
Hot off the digital press, the latest AGE-WELL annual report, AgeTech for Aging Well, showcases recent activities and accomplishments from across the ...

Kuopio Health’s member is a pioneer in sustained-release delivery technology for the treatment of eye diseases

9 Dec 2024
ReBio Technologies is a biotechnology company established in 2015 with a focus on sustained-release delivery technology, especially in the treatment o...

From Portugal to the World: 2024 in review, 2025 horizon

9 Dec 2024
Health Portugal has united the Portuguese health value chain, nearly doubling exports between 2020 and 2023. The brand’s 2024 milestones include globa...

Have your say: Online Public Consultation for the development of a future Skills Strategy for the healthcare sector

4 Dec 2024

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *